These data explain the elevated levels of PAI-1 in conditions characterized by hyperinsulinemia and hyperglycemia such as obesity, metabolic syndrome, and type 2 diabetes mellitus [25,144,145]. This evidence concerns the gene SERPINE1 and metabolic syndrome.